In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 21393131)

Published in J Antimicrob Chemother on March 08, 2011

Authors

D W Wareham1, N C Gordon, M Hornsey

Author Affiliations

1: Centre for Immunology and Infectious Disease, Blizard Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, UK. d.w.wareham@qmul.ac.uk

Articles citing this

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45

In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother (2011) 1.25

Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother (2013) 1.04

In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother (2012) 1.03

Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria. Antimicrob Agents Chemother (2013) 0.97

Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother (2013) 0.95

Advances in antibiotic therapy in the critically ill. Crit Care (2016) 0.94

A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii. Infect Dis Ther (2014) 0.91

In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother (2014) 0.91

In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob Agents Chemother (2012) 0.91

Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases (2014) 0.88

Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use. Pharmacotherapy (2015) 0.86

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis (2014) 0.82

How to treat VAP due to MDR pathogens in ICU patients. BMC Infect Dis (2014) 0.81

In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam. J Med Microbiol (2015) 0.78

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit. BMC Infect Dis (2015) 0.78

Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. PLoS One (2016) 0.77

In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2014) 0.76

Biofilm Production Correlating with Multidrug Resistance Among Clinical Isolates of Acinetobacter baumannii. J Clin Diagn Res (2015) 0.76

Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage ØABP-01 Endolysin (LysABP-01) in Combination with Colistin. Front Microbiol (2016) 0.75

In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2015) 0.75

Synergistic combinations of polymyxins. Int J Antimicrob Agents (2016) 0.75

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria. Infect Dis Ther (2015) 0.75

Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria. Sci Rep (2016) 0.75

Clinical Pharmacokinetics and Pharmacodynamics of Colistin. Clin Pharmacokinet (2017) 0.75

Articles by these authors

The mechanism of placebo analgesia. Lancet (1978) 4.10

Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27

Intranasal Teeth. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol (1979) 1.73

The narcotic antagonist naloxone enhances clinical pain. Nature (1978) 1.66

Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature (1979) 1.63

Fixation of mandibular fractures: a comparative analysis of rigid internal fixation and standard fixation techniques. J Oral Maxillofac Surg (1990) 1.37

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain (1999) 1.33

The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci (2001) 1.29

Influence of the method of drug administration on analgesic response. Nature (1985) 1.27

Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett (1996) 1.21

Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain (1981) 1.15

Role of pain in placebo analgesia. Proc Natl Acad Sci U S A (1979) 1.08

Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol (2013) 1.02

High-level bacterial expression and 15N-alanine-labeling of bovine trypsin. Application to the study of trypsin-inhibitor complexes and trypsinogen activation by NMR spectroscopy. Biochemistry (2001) 0.97

Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation. Biochemistry (2000) 0.91

Polymicrobial necrotizing fasciitis involving enterobacteria producing CTX-M-15 extended-spectrum β-lactamases. J Med Microbiol (2010) 0.89

Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii. J Clin Pathol (2010) 0.88

Method of administration determines the effect of naloxone on pain. Brain Res (1986) 0.86

Soft tissue surgery in the oral and maxillofacial region. J Calif Dent Assoc (2000) 0.85

Post-operative pain: effect of extent of injury and attention. Brain Res (1982) 0.85

Desipramine enhances opiate postoperative analgesia. Pain (1986) 0.83

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. Eur J Clin Microbiol Infect Dis (2013) 0.83

Allele-specific polymerase chain reaction (PCR) for rapid detection of the aac(6')-Ib-cr quinolone resistance gene. Int J Antimicrob Agents (2010) 0.81

Medical palatine cyst and maxillary antral osteoma: report of an unusal case. J Oral Surg (1980) 0.80

Cardiovascular autonomic response during preoperative stress and postoperative pain. Pain (1984) 0.79

Benzodiazepine mediated antagonism of opioid analgesia. Pain (1997) 0.79

Potentiation of pentazocine analgesia by low-dose naloxone. J Clin Invest (1988) 0.79

Enhancement of morphine analgesia by the alpha 2-adrenergic antagonist yohimbine. Neuroscience (1995) 0.79

Pain-induced vocalization in the rat and its modification by pharmacological agents. Brain Res (1984) 0.78

Pain in prelingual children and its evaluation by pain-induced vocalization. Pain (1982) 0.78

A spinal opioid synapse mediates the interaction of spinal and brain stem sites in morphine analgesia. Brain Res (1982) 0.78

The role of stimulus intensity and stress in opioid-mediated analgesia. Brain Res (1984) 0.78

Synergism between the analgesic actions of morphine and pentazocine. Pain (1988) 0.78

Naloxone fails to antagonize nitrous oxide analgesia for clinical pain. Pain (1982) 0.78

Closure of oronasoantral defects: report of case. J Oral Surg (1980) 0.77

The effects of local hypothermia on odontogenesis. J Oral Surg (1979) 0.76

An aura of enlightenment. J Oral Maxillofac Surg (1994) 0.75

Soft tissue injuries. J Can Dent Assoc (1980) 0.75

Psychosedation anesthesia in dental practice. ICD Sci Educ J (1978) 0.75

Relationship of duration of analgesia to opioid pharmacokinetic variables. Brain Res (1983) 0.75

Lead poisoning. A comprehensive review and report of a case. Oral Surg Oral Med Oral Pathol (1979) 0.75

Delayed rupture of the spleen in a patient with mandibular fracture. J Oral Surg (1979) 0.75

Self-instruction guides in the undergraduate oral surgery curriculum. Oral Surg Oral Med Oral Pathol (1981) 0.75

Altered electrodermal responsivity associated with clinical pain. Pain (1983) 0.75

Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon. J Antimicrob Chemother (2009) 0.75

Physiological substrates of placebo analgesia. Psychopharmacol Bull (1981) 0.75